Recall
FDAHealthJanuary 29, 2026

Teva Pharmaceuticals USA, Inc — Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11

⚠️ Failed Dissolution Specifications

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
January 29, 2026

Nationwide

What's affected?

Product
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Lot code
a)

Additional details

Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. .

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 19,056 bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.